Skip to main content

Phytolon closes $23.6M Series B to commercialize fermentation-based natural food colors

Israeli startup Phytolon closes a $23.6M Series B to scale precision-fermented pigments, starting with an FDA-approved beetroot red.

Phytolon closes $23.6M Series B to commercialize fermentation-based natural food colors

Phytolon, an Israeli biotechnology company, announced the successful close of its $23.6 million Series B financing round. This funding injection directly supports the commercialization of its precision-fermentation based natural food colors, addressing a global acceleration in demand for high-quality natural alternatives.

The financing follows the recent FDA approval of "Beetroot Red," Phytolon's first natural colorant produced through engineered baker's yeast. This product offers a cost-effective, robust, and sustainable alternative to synthetic dyes, and its effective date is subject to FDA procedures.

Led by an undisclosed strategic investor, the three-stage round saw participation from existing investors including Millennium Foodtech, NextGen Nutrition Investment Partners (NGN), Colorcon Ventures, and Yossi Ackerman. NGN highlighted Phytolon’s position at the nexus of consumer and regulatory demand for natural ingredients.

With this new funding, Phytolon aims to expand sales and supply to CPGs and distribution partners in the U.S. and globally. CEO Halim Jubran noted the increased portfolio of strategic investors will further establish the company's market footprint.

Source: BevNET